Livzon Pharmaceutical Group Inc.
000513
Hisse Senetlerindeki Sıralama
#4689
Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and... Livzon Pharmaceutical Group Inc., headquartered in Zhuhai, China, and established in 1985, is a biopharmaceutical enterprise operating across the entire spectrum of pharmaceutical activities, from research and development to manufacturing and commercialization. The company's operations encompass a diverse range of finished drug products, active pharmaceutical ingredients (APIs), and chemical intermediates, primarily serving the Chinese market while also engaging in international exports. Its pharmaceutical portfolio includes treatments such as Ilaprazole enteric coated tablets for duodenal ulcers and reflux esophagitis, Laprazole sodium injection for managing peptic ulcer bleeding, Leuprorelin Acetate Microspheres for injection, and Urofollitropin injection for anovulation and fertility support. Livzon also produces Perospirone Hydrochloride for schizophrenia, Anti-viral Granules targeting upper respiratory tract infections and influenza, and Shenqi Fuzheng Injection, which addresses general weakness, fatigue, spontaneous sweating, and vertigo, and provides supportive care for lung and stomach cancer patients. Beyond therapeutic drugs, Livzon Pharmaceutical Group develops and distributes a variety of diagnostic reagents. These include kits for detecting IgM/IgG antibodies to coronavirus, nucleic acid tests for human immunodeficiency virus type 1, antinuclear antibody test kits, interferon-gamma release assay kits, and rapid tests for mycoplasma pneumoniae IgM antibodies. The company's extensive offerings further extend to biochemical drugs, microbiological preparations, biologics, traditional Chinese medicine formulations, pharmaceutical raw materials, and antibiotics.
Hisse Fiyatı
$3.90
Piyasa Değeri
$3.17B
Değişim (1 gün)
-3.49%
Değişim (1 yıl)
-25.88%
Ülke
CN
Ticaret Livzon Pharmaceutical Group Inc. (000513)
Kategori
Healthcare
Livzon Pharmaceutical Group Inc. (000513) için tedavüldeki hisse sayısı
June 2026 itibarıyla tedavüldeki hisse sayısı: 887.91M
Livzon Pharmaceutical Group Inc. şirketinin son finansal raporlarına ve hisse fiyatına göre, mevcut tedavüldeki hisse sayısı 887.91M'dir. December 2024 sonunda şirketin 920.13M tedavüldeki hissesi vardı. Tedavüldeki hisse sayısı genellikle hisse bölünmeleri ve hisse geri alımları ile etkilenir.
Livzon Pharmaceutical Group Inc. (000513) için 2001 - 2026 tarihleri arasındaki hisse geçmişi
Her yıl sonunda tedavüldeki hisse sayısı
| Yıl | Tedavüldeki Hisse Sayısı | Değiştir |
|---|---|---|
| 2026 (TTM) | 887.91M | -0.58% |
| 2025 | 893.10M | -2.94% |
| 2024 | 920.13M | -1.09% |
| 2023 | 930.31M | -0.50% |
| 2022 | 934.98M | 0.06% |
| 2021 | 934.46M | -0.18% |
| 2020 | 936.16M | 0.15% |
| 2019 | 934.76M | 0.20% |
| 2018 | 932.91M | 0.79% |
| 2017 | 925.61M | 6.14% |
| 2016 | 872.08M | 3.28% |
| 2015 | 844.41M | -0.18% |
| 2014 | 845.97M | 0.25% |
| 2013 | 843.85M | -0.32% |
| 2012 | 846.60M | 0.63% |
| 2011 | 841.31M | -0.68% |
| 2010 | 847.07M | -0.85% |
| 2009 | 854.31M | -2.35% |
| 2008 | 874.86M | 0.01% |
| 2007 | 874.81M | -0.21% |
| 2006 | 876.62M | 0.21% |
| 2005 | 874.81M | 0.00% |
| 2004 | 874.81M | 0.00% |
| 2003 | 874.81M | 0.00% |
| 2002 | 874.81M | 0.00% |
| 2001 | 874.81M | 0.00% |
Benzer şirketler veya rakipler için tedavüldeki hisse sayısı
| Şirket | Tedavüldeki Hisse Sayısı | Fark | Ülke |
|---|---|---|---|
| 434.78M | -51.03% |
DE
|
|
| 434.78M | -51.03% |
DE
|
|
| 1.56B | 75.98% |
JP
|
|
| 233.66M | -73.68% |
CH
|
|
| 2.40B | 170.22% |
IN
|
